first realized Malcolm Dole's dream of electrospray ionization (ESI) (1), the broad impact it would ultimately have was not obvious to most researchers working in the (admittedly much smaller) field at the time (2). Indeed, between his first publication in 1984 and ground breaking report in 1988 that described ESI-mass spectrometry (ESI-MS) as a tool for analyzing large proteins (3), my laboratory was one of the very few (and perhaps the only?) working with ESI-MS (4). After Fenn's 1988 seminal publication, the MS community broadly recognized the potential of ESI-MS for providing the long sought effective interface between liquid chromatography (LC) separations and MS that would allow a large range of previously intractable biomolecules to be studied.
Perspective
ESI that cause nonlinear responses with abundance, and to different detection efficiencies for different species (13) . Analyses performed with even the smallest column bore diameter commonly used for capillary LC can result in significant compoundto-compound variations and nonlinear ESI-MS responses, particularly at higher concentrations. Under these conditions, differences in LC-MS peak intensities may not correctly reflect changes in abundance. Present MS instrumentation is increasingly able to make the most of nanoLC-nanoESI performance. Early ESI-MS instruments suffered due to inefficient ion transmission to the detector. Generally, the greatest ion losses occur in higher pressure regions of the MS (i.e., closest to the ESI source). By using collisional focusing at pressures of <10 -2 Torr in radio frequency (RF) ion guides (14) , >50% ion transmission efficiency can now be achieved, which means a well-designed mass spectrometer can have overall ion transmission and detection efficiencies in its intermediate-to-lower pressure regions that significantly exceed 10%. The electrodynamic ion funnel has proven highly effective for minimizing loses through the first MS vacuum stage (typically at a pressure of 1-5 Torr) (15); ion transmission efficiency through the funnel is essentially 100% over a wide mass-to-charge ratio (m/z) range. As a result, the extent to which ions are efficiently utilized in analyses is then dictated by the type of instrument and operational details; for example, Belov et al. (16) showed overall ion utilization (from ionization through detection) of 7%-10% that provided low zeptomole detection limits for proteins analyzed by Fourier-transform ion cyclotron resonance (FTICR) instrumentation. Another improvement has derived from the use of automated gain control (AGC) with ion trapping instrumentation, which constrains ion populations in ion traps (e.g., quadrupole and FTICR) to levels that maintain the desired mass measurement accuracy. The greatest sensitivity for these instruments is obtained for LC separation fractions that provide the lowest signal intensities (where accumulation times are longest). Highly abundant species tend to shorten useful accumulation times and thus preclude detection of otherwise detectable low abundance species in the same spectrum. Since the present maximum ion transmission rates from an ESI source (>10 8 charge/s) can exceed FTICR capacity by >100-fold, potentially useful signal is often wasted. Application of the dynamic range enhancement applied to mass spectrometry (DREAMS) method is a powerful tactic for overcoming wasted signal (17) . With DREAMS, a normal mass spectrum is followed by a spectrum in which the most abundant ions detected in the previous spectrum are removed. As a result, the overall dynamic range can be extended by >10-fold, which in turn provides large increases in proteome coverage.
Finally, I believe that the ultimate limitations for ESI-MS analyses stem from the number of ions that can be analyzed in a given time frame. Too few ions, even for the most effective analyzers, limit the quality of the data in addition to the depth and speed of the analysis. New developments, such as multi-emitter nanoESI sources (18) , can potentially increase the dynamic range of measurements and indirectly provide higher analysis throughput. Perhaps more importantly, such approaches present opportunities for greatly enhancing the quantitative value of measurements, but at higher and easier to use liquid flow rates. Such developments will continue to expand the role of ESI-MS in biological research and, increasingly, extend its use in important clinical applications. 
